Zan Shen

4PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 05, 2024
Safety and efficacy of fruquintinib-based therapy in patients with advanced or metastatic sarcoma.

Chenliang Zhou, Guowei Qian, Yonggang Wang

|May 15, 2023
Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.

Yansong Lin, Shukui Qin, Hui Yang

|Dec 05, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.

Yan Zhou, Qingcheng Yang, Yang Dong

|Apr 10, 2019
Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.

L Tang, W Yu, Y Wang

Pageof 1

Frequent Collaborators

2 joint publications

Shuier Zheng

2 joint publications

Chenliang Zhou

2 joint publications

Guowei Qian

1 joint publications

Yan Zhou